U Lippi
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
-
- Platelet Disorders and Treatments
Papers in
- Surgery 8
- Lipoproteins and Cardiovascular Health 7
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Co-authors
- G. M. Guidi (2 shared papers)Ciro D’Orazio (2 shared papers)Bengt Sylvén (1 shared paper)G. Mastella (1 shared paper)Giuseppe Lippi (6 shared papers)Maria Stella Graziani (6 shared papers)E Cecchin (3 shared papers)Franco Tesio (3 shared papers)
In The Last Decade
U Lippi
31 papers receiving 284 citations
Peers
Comparison fields: 5 of 79
- Endocrinology, Diabetes and Metabolism 68
- Hematology 29
- Transplantation 6
- Internal Medicine 7
- Pulmonary and Respiratory Medicine 60
Countries citing papers authored by U Lippi
This map shows the geographic impact of U Lippi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U Lippi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U Lippi more than expected).
Fields of papers citing papers by U Lippi
This network shows the impact of papers produced by U Lippi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U Lippi. The network helps show where U Lippi may publish in the future.
Co-authors
The 23 scholars most cited alongside U Lippi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 51 | |
| 2 | 1970 | 42 | |
| 3 | EDTA-induced platelet aggregation can be avoided by a new anticoagulant also suitable for automated complete blood count. | 1990 | 25 |
| 4 | 1965 | 20 | |
| 5 | Origin of glycosylated hemoglobin A1 in chronic renal failure. | 1983 | 18 |
| 6 | 1983 | 17 | |
| 7 | 1987 | 16 | |
| 8 | 2008 | 12 | |
| 9 | Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens. | 1993 | 12 |
| 10 | 1993 | 10 | |
| 11 | 1972 | 9 | |
| 12 | 1990 | 9 | |
| 13 | 1985 | 7 | |
| 14 | 1983 | 7 | |
| 15 | 1988 | 6 | |
| 16 | 1986 | 5 | |
| 17 | 1992 | 5 | |
| 18 | 1984 | 5 | |
| 19 | Alpha-naphthyl butyrate esterase (a selective cytochemical monocyte marker). | 1984 | 5 |
| 20 | 1983 | 4 |
About U Lippi
U Lippi is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Molecular Biology, Hematology and Cancer Research, having authored 33 papers that have together received 310 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Cancer, Lipids, and Metabolism (5 papers), Glycosylation and Glycoproteins Research (3 papers), Dialysis and Renal Disease Management (3 papers), Clinical Laboratory Practices and Quality Control (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (68 citations), Hematology (29 citations), Transplantation (6 citations), Internal Medicine (7 citations) and Pulmonary and Respiratory Medicine (60 citations). U Lippi has collaborated with scholars based in Italy and Sweden. Frequent co-authors include G. M. Guidi, Ciro D’Orazio, Bengt Sylvén, G. Mastella, Giuseppe Lippi, Maria Stella Graziani, E Cecchin, Franco Tesio, Alessandra Raimondi and Santino Marchi. Their work appears in journals such as Clinical Chemistry, Clinica Chimica Acta, American Journal of Clinical Pathology, European Journal of Pediatrics and International Journal of Clinical & Laboratory Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.